Overview
Kemper Corporation, based in the United States, operates predominantly in the insurance industry. The company provides a diverse range of insurance products including auto, home, life, and health insurance geared primarily toward individual consumers. Kemper's strategy revolves around offering tailored solutions that cater to the unique needs of its customers, leveraging a broad distribution network that includes agents, brokers, and direct sales. Key projects involve implementing advanced digital technologies to enhance customer service and claims processing efficiency, as well as expanding its market footprint through strategic acquisitions aimed at broadening its service offerings and geographic reach. Overall, Kemper Corporation focuses on sustainable growth by improving operational efficiencies and maintaining strong customer relationships.
Basic Stats
The share price of Kemper Corporation - Depositary Receipt (Common Stock) as of September 4, 2025 is R$212.10 / share. This is a decrease of 0.00% from the prior week. The market cap (or net worth) of Kemper Corporation - Depositary Receipt (Common Stock) as of September 5, 2025 is R$13,484.52 MM.
The Factor Analysis chart (below right) shows a view of Kemper Corporation - Depositary Receipt (Common Stock) from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 13,484.52 MM |
| EV | |
| Shares Out. | 63.58 MM |
| Earnings Date | |
| EPS (TTM) | 5.40 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | 22.35 % |
| Volatility (1 yr) | 0.12 |
| Beta | 0.09 |
| Sharpe Ratio (1 yr) | 1.47 |
| Sortino Ratio (1 yr) | 24.91 |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.03 |
| ROE | 0.13 |
| ROIC | 0.08 |
| CROIC | 0.02 |
| OCROIC | 0.13 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 13.63 /100 |
| Profitability | 69.74 /100 |
| Quality Score | 39.00 /100 |
| Value Score | |
| Momentum Score | 40.61 /100 |
| Stability (Low Vol) Score | 25.36 /100 |
| Analyst Sentiment | 60.98 /100 |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 9.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Kemper Corporation - Depositary Receipt (Common Stock) is R$266.02. The forecasts range from a low of R$240.36 to a high of R$290.96. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Kemper Corporation - Depositary Receipt (Common Stock). An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-04-15 | JMP Securities | Market Outperform | Market Outperform | Reiterate |
| 2024-04-01 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-02-05 | UBS | Buy | Buy | Maintains |
| 2024-01-26 | Raymond James | Strong Buy | Strong Buy | Maintains |
| 2024-01-25 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-01-10 | UBS | Buy | Buy | Maintains |
| 2023-12-19 | Piper Sandler | Overweight | Overweight | Maintains |
| 2023-10-24 | Raymond James | Strong Buy | Strong Buy | Maintains |
| 2023-10-24 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2023-10-06 | Piper Sandler | Neutral | Overweight | Upgrade |
| 2023-07-12 | JMP Securities | Market Outperform | Market Outperform | Reiterate |
| 2023-07-06 | Piper Sandler | Neutral | Neutral | Maintains |
| 2023-05-09 | Piper Sandler | Neutral | Maintains | |
| 2023-05-08 | Credit Suisse | Outperform | Reiterate | |
| 2023-05-01 | Raymond James | Strong Buy | Maintains | |
| 2023-04-18 | JMP Securities | Market Outperform | Reiterate | |
| 2023-04-10 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2023-04-04 | Piper Sandler | Neutral | Maintains | |
| 2023-03-14 | JMP Securities | Market Outperform | Reiterate | |
| 2023-03-10 | Credit Suisse | Neutral | Reiterate | |
| 2023-02-07 | Raymond James | Outperform | Strong Buy | Upgrade |
| 2023-02-06 | JMP Securities | Market Outperform | Reiterate | |
| 2023-01-30 | Credit Suisse | Underperform | Neutral | Upgrade |
| 2022-11-04 | Raymond James | Market Perform | Outperform | Upgrade |
| 2022-08-02 | Piper Sandler | Neutral | Maintains | |
| 2022-05-03 | JMP Securities | Market Outperform | Maintains | |
| 2022-04-28 | Credit Suisse | Underperform | Initiate | |
| 2022-02-01 | Raymond James | Outperform | Market Perform | Downgrade |
| 2021-11-01 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2021-08-02 | Raymond James | Outperform | Maintains | |
| 2021-07-19 | Raymond James | Strong Buy | Outperform | Downgrade |
| 2021-05-04 | Raymond James | Strong Buy | Maintains | |
| 2021-03-11 | Raymond James | Strong Buy | Maintains | |
| 2020-10-19 | Raymond James | Strong Buy | Maintains | |
| 2020-08-06 | Raymond James | Strong Buy | Maintains | |
| 2020-04-24 | Raymond James | Strong Buy | Maintains | |
| 2020-04-16 | JMP Securities | Market Outperform | Maintains | |
| 2020-04-06 | Piper Sandler | Overweight | Maintains | |
| 2020-04-03 | Raymond James | Strong Buy | Maintains | |
| 2019-09-10 | UBS | Buy | Initiate | |
| 2019-09-09 | UBS | Buy | Initiate | |
| 2019-08-23 | William Blair | Outperform | Market Perform | Downgrade |
| 2019-02-12 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2019-01-08 | JMP Securities | Market Perform | Outperform | Upgrade |
| 2018-11-02 | Keefe Bruyette & Woods | Market Perform | Initiate | |
| 2017-08-03 | Raymond James | Market Perform | Strong Buy | Upgrade |
| 2016-08-10 | Janney Capital | Buy | Neutral | Downgrade |
| 2016-05-09 | Sandler O'Neill | Buy | Hold | Downgrade |
| 2016-04-05 | Janney Capital | Buy | Initiate | |
| 2016-02-18 | Sandler O'Neill | Hold | Buy | Upgrade |
| 2015-07-20 | Sandler O'Neill | Buy | Hold | Downgrade |
| 2024-07-17 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2024-08-13 | UBS | Buy | Buy | Maintains |
| 2024-08-06 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2024-08-06 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-12-26 | Raymond James | Strong Buy | Strong Buy | Maintains |
| 2024-08-08 | Raymond James | Strong Buy | Strong Buy | Maintains |
| 2025-08-07 | Raymond James | Strong Buy | Outperform | Downgrade |
| 2025-02-06 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-11-19 | TD Cowen | Buy | Buy | Maintains |
| 2024-10-15 | JMP Securities | Market Outperform | Market Outperform | Reiterate |
| 2025-08-06 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2025-08-06 | Piper Sandler | Overweight | Underweight | Downgrade |
| 2025-05-08 | Piper Sandler | Overweight | Overweight | Maintains |
